Who are Vessel's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Human Growth Hormone, Hormone, A single "booster" dose of the Moderna mRNA COVID-19 vaccine, Guna-Rhino Nose, Allergies, Allium Sativum.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vessel.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Vessel — Competitive Intelligence Brief

Vessel (Vessel) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Standardized Insect Venom Allergenic Extract [EPC]. Area: Other.

marketed Standardized Insect Venom Allergenic Extract [EPC] Other Small molecule Live · refreshed every 30 min

Target snapshot

Vessel (Vessel) — Value Outcomes Ltd..

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Vessel TARGET	Vessel	Value Outcomes Ltd.	marketed	Standardized Insect Venom Allergenic Extract [EPC]
Human Growth Hormone	Human Growth Hormone	Center for Human Reproduction	marketed	Standardized Insect Venom Allergenic Extract [EPC]
Hormone	Hormone	Assiut University	marketed	Standardized Insect Venom Allergenic Extract [EPC]
A single "booster" dose of the Moderna mRNA COVID-19 vaccine	A single "booster" dose of the Moderna mRNA COVID-19 vaccine	Barbara Ann Karmanos Cancer Institute	marketed	Standardized Insect Venom Allergenic Extract [EPC]
Guna-Rhino Nose	INTERLEUKIN-10	Guna spa	marketed	Standardized Insect Venom Allergenic Extract [EPC]
Allergies	CAPSICUM	Newton Laboratories, Inc.	marketed	Standardized Insect Venom Allergenic Extract [EPC]
Allium Sativum	Allium Sativum	Suez Canal University	marketed	Standardized Insect Venom Allergenic Extract [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Standardized Insect Venom Allergenic Extract [EPC] class)

Assiut University · 1 drug in this class
Barbara Ann Karmanos Cancer Institute · 1 drug in this class
Center for Human Reproduction · 1 drug in this class
Guna spa · 1 drug in this class
Newton Laboratories, Inc. · 1 drug in this class
Suez Canal University · 1 drug in this class
Value Outcomes Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vessel — Competitive Intelligence Brief. https://druglandscape.com/ci/vessel. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab